The Food and Drug Administration wants to unveil a new, more efficient risk-based regulatory approach to digital health technologies focused on fostering innovation and bringing these products to market more rapidly.

Writing in a June 15 blog, FDA Commissioner Scott Gottlieb, MD, outlined the agency’s forthcoming Digital Health Innovation Plan, the goal of which is to ensure the agency has the most modern and efficient regulatory approaches to evaluate new technologies that will ultimately benefit consumers.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access